NCT02533908View on ClinicalTrials.gov

Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

September 21, 2015

Primary Completion Date

October 12, 2017

Study Completion Date

October 12, 2017

Conditions
Inhalation of Nitrous OxideOpioid Analgesic Adverse ReactionPain
Interventions
DRUG

Fentanyl intranasal

fentanyl is applied intranasally with a MAD (mucosal atomization device) prior to the application of nitrous oxide 70% analgosedation

DRUG

NaCl 0.9% intranasal

Placebo is applied intranasally with a MAD (mucosal atomization device) Prior to the application of nitrous oxide 70% analgosedation

Trial Locations (1)

8032

Children's Hospital, Zurich

All Listed Sponsors
lead

University Children's Hospital, Zurich

OTHER

NCT02533908 - Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children | Biotech Hunter | Biotech Hunter